Cargando…

Pharmacological basis of the use of the root bark of Zizyphus nummularia Aubrev. (Rhamnaceae) as anti-inflammatory agent

BACKGROUND: The root bark of Zizyphus nummularia (Rhamnaceae) is traditionally used as an anti-inflammatory agent. The current study aimed to explore the anti-inflammatory activity (in vivo) of a crude ethanolic extract (EE) and the pure identified octadecahydro-picene-2,3,14,15-tetranone (IC) in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Ray, Sarbani Dey, Ray, Supratim, Zia-Ul-Haq, Muhammad, De Feo, Vincenzo, Dewanjee, Saikat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657250/
https://www.ncbi.nlm.nih.gov/pubmed/26597878
http://dx.doi.org/10.1186/s12906-015-0942-7
_version_ 1782402362831273984
author Ray, Sarbani Dey
Ray, Supratim
Zia-Ul-Haq, Muhammad
De Feo, Vincenzo
Dewanjee, Saikat
author_facet Ray, Sarbani Dey
Ray, Supratim
Zia-Ul-Haq, Muhammad
De Feo, Vincenzo
Dewanjee, Saikat
author_sort Ray, Sarbani Dey
collection PubMed
description BACKGROUND: The root bark of Zizyphus nummularia (Rhamnaceae) is traditionally used as an anti-inflammatory agent. The current study aimed to explore the anti-inflammatory activity (in vivo) of a crude ethanolic extract (EE) and the pure identified octadecahydro-picene-2,3,14,15-tetranone (IC) in the root bark of Z. nummularia. IC was further subjected to suitable in vitro and in silico studies to find out the mechanistic pharmacology. METHODS: EE (100 and 200 mg/kg, p.o.) and (IC) (400 and 600 μg/kg, p.o.) were subjected to in vivo anti-inflammatory assays to evaluate the anti-inflammatory activity and predict the probable mechanism(s) of action. Suitable acute (carrageenan-induced paw edema, arachidonic acid-induced ear edema, xylene-induced ear edema) and chronic (cotton pellet granuloma) models were employed to investigate in vivo the anti-inflammatory activity. Based on in vivo observation, IC was further subjected to in vitro assays to estimate the inhibition of nitric oxide (NO), prostaglandin-E(2) (PGE-2) and tumor necrosis factor-α (TNF-α) production in PBS stimulated RAW 264.7 cells. Based on the observation of in vitro studies, finally, ADME prediction and molecular docking studies of IC were performed for better understanding of interaction of IC with TNF-α. RESULTS: Oral administration of EE (100 and 200 mg/kg) exhibited significant inhibition of carrageenan (p < 0.05) and arachidonic acid (p < 0.05) induced oedema, and the reduced the granuloma tissue formation (p < 0.05) in experimental mice. IC (400 and 600 μg/kg, p.o.) exhibited significant (p < 0.01) inhibition of carrageenan, xylene and arachidonic acid-induced edema, and reduced the granuloma tissue formation. In in vitro assays, IC caused a concentration-dependent inhibition of LPS stimulated NO (up to ~ 67.4 % at 50 μM) and TNF-α (~84.5 % at 50 μM) production. However, the PGE-2 inhibition did not follow dose dependent pattern. Based on in vitro observations, the molecular docking has been performed on the basis of interaction with TNF-α. In in silico studies, it was observed that IC showed hydrogen bonding with GLN 47 amino acid residue of TNF-α protein. CONCLUSIONS: IC possibly produces anti-inflammatory activity through inhibition of TNF-α and NO production. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12906-015-0942-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4657250
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46572502015-11-25 Pharmacological basis of the use of the root bark of Zizyphus nummularia Aubrev. (Rhamnaceae) as anti-inflammatory agent Ray, Sarbani Dey Ray, Supratim Zia-Ul-Haq, Muhammad De Feo, Vincenzo Dewanjee, Saikat BMC Complement Altern Med Research Article BACKGROUND: The root bark of Zizyphus nummularia (Rhamnaceae) is traditionally used as an anti-inflammatory agent. The current study aimed to explore the anti-inflammatory activity (in vivo) of a crude ethanolic extract (EE) and the pure identified octadecahydro-picene-2,3,14,15-tetranone (IC) in the root bark of Z. nummularia. IC was further subjected to suitable in vitro and in silico studies to find out the mechanistic pharmacology. METHODS: EE (100 and 200 mg/kg, p.o.) and (IC) (400 and 600 μg/kg, p.o.) were subjected to in vivo anti-inflammatory assays to evaluate the anti-inflammatory activity and predict the probable mechanism(s) of action. Suitable acute (carrageenan-induced paw edema, arachidonic acid-induced ear edema, xylene-induced ear edema) and chronic (cotton pellet granuloma) models were employed to investigate in vivo the anti-inflammatory activity. Based on in vivo observation, IC was further subjected to in vitro assays to estimate the inhibition of nitric oxide (NO), prostaglandin-E(2) (PGE-2) and tumor necrosis factor-α (TNF-α) production in PBS stimulated RAW 264.7 cells. Based on the observation of in vitro studies, finally, ADME prediction and molecular docking studies of IC were performed for better understanding of interaction of IC with TNF-α. RESULTS: Oral administration of EE (100 and 200 mg/kg) exhibited significant inhibition of carrageenan (p < 0.05) and arachidonic acid (p < 0.05) induced oedema, and the reduced the granuloma tissue formation (p < 0.05) in experimental mice. IC (400 and 600 μg/kg, p.o.) exhibited significant (p < 0.01) inhibition of carrageenan, xylene and arachidonic acid-induced edema, and reduced the granuloma tissue formation. In in vitro assays, IC caused a concentration-dependent inhibition of LPS stimulated NO (up to ~ 67.4 % at 50 μM) and TNF-α (~84.5 % at 50 μM) production. However, the PGE-2 inhibition did not follow dose dependent pattern. Based on in vitro observations, the molecular docking has been performed on the basis of interaction with TNF-α. In in silico studies, it was observed that IC showed hydrogen bonding with GLN 47 amino acid residue of TNF-α protein. CONCLUSIONS: IC possibly produces anti-inflammatory activity through inhibition of TNF-α and NO production. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12906-015-0942-7) contains supplementary material, which is available to authorized users. BioMed Central 2015-11-23 /pmc/articles/PMC4657250/ /pubmed/26597878 http://dx.doi.org/10.1186/s12906-015-0942-7 Text en © Ray et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Ray, Sarbani Dey
Ray, Supratim
Zia-Ul-Haq, Muhammad
De Feo, Vincenzo
Dewanjee, Saikat
Pharmacological basis of the use of the root bark of Zizyphus nummularia Aubrev. (Rhamnaceae) as anti-inflammatory agent
title Pharmacological basis of the use of the root bark of Zizyphus nummularia Aubrev. (Rhamnaceae) as anti-inflammatory agent
title_full Pharmacological basis of the use of the root bark of Zizyphus nummularia Aubrev. (Rhamnaceae) as anti-inflammatory agent
title_fullStr Pharmacological basis of the use of the root bark of Zizyphus nummularia Aubrev. (Rhamnaceae) as anti-inflammatory agent
title_full_unstemmed Pharmacological basis of the use of the root bark of Zizyphus nummularia Aubrev. (Rhamnaceae) as anti-inflammatory agent
title_short Pharmacological basis of the use of the root bark of Zizyphus nummularia Aubrev. (Rhamnaceae) as anti-inflammatory agent
title_sort pharmacological basis of the use of the root bark of zizyphus nummularia aubrev. (rhamnaceae) as anti-inflammatory agent
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657250/
https://www.ncbi.nlm.nih.gov/pubmed/26597878
http://dx.doi.org/10.1186/s12906-015-0942-7
work_keys_str_mv AT raysarbanidey pharmacologicalbasisoftheuseoftherootbarkofzizyphusnummulariaaubrevrhamnaceaeasantiinflammatoryagent
AT raysupratim pharmacologicalbasisoftheuseoftherootbarkofzizyphusnummulariaaubrevrhamnaceaeasantiinflammatoryagent
AT ziaulhaqmuhammad pharmacologicalbasisoftheuseoftherootbarkofzizyphusnummulariaaubrevrhamnaceaeasantiinflammatoryagent
AT defeovincenzo pharmacologicalbasisoftheuseoftherootbarkofzizyphusnummulariaaubrevrhamnaceaeasantiinflammatoryagent
AT dewanjeesaikat pharmacologicalbasisoftheuseoftherootbarkofzizyphusnummulariaaubrevrhamnaceaeasantiinflammatoryagent